Research Progress on the Correlation Between Hypertension and Gut Microbiota

References

• Saiz LC, Gorricho J, Garjón J, Celaya MC, Erviti J, Leache L. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Cochrane Database Syst Rev. 2022;11(11):CD010315. doi:10.1002/14651858.CD010315.pub5
   PubMedGoogle Scholar
• GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. doi:10.1016/S0140-6736(20)30925-9
   PubMed Web of Science ®Google Scholar
• GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–1249. doi:10.1016/S0140-6736(20)30752-2
   PubMed Web of Science ®Google Scholar
• Kawarazaki W, Fujita T. Kidney and epigenetic mechanisms of salt-sensitive hypertension. Nat Rev Nephrol. 2021;17(5):350–363. doi:10.1038/s41581-021-00399-2
   PubMed Web of Science ®Google Scholar
• Tang WHW, Bäckhed F, Landmesser U, et al. Intestinal microbiota in cardiovascular health and disease: JACC State-of-The-Art Review. J Am Coll Cardiol. 2019;73(16):2089–2105. doi:10.1016/j.jacc.2019.03.024
   PubMed Web of Science ®Google Scholar
• Verhaar BJH, Prodan A, Nieuwdorp M, et al. Gut microbiota in hypertension and atherosclerosis: a review. Nutrients. 2020;12(10):2982. doi:10.3390/nu12102982
   PubMed Web of Science ®Google Scholar
• Duttaroy AK. Role of gut microbiota and their metabolites on atherosclerosis, hypertension and human blood platelet function: a review. Nutrients. 2021;13(1):144. doi:10.3390/nu13010144
   PubMed Web of Science ®Google Scholar
• Joe B, McCarthy CG, Edwards JM, et al. Microbiota introduced to germ-free rats restores vascular contractility and blood pressure. Hypertension. 2020;76(6):1847–1855. doi:10.1161/HYPERTENSIONAHA.120.15939
   PubMed Web of Science ®Google Scholar
• Tindall AM, McLimans CJ, Petersen KS, et al. Walnuts and vegetable oils containing oleic acid differentially affect the gut microbiota and associations with cardiovascular risk factors: follow-up of a randomized, controlled, feeding trial in adults at risk for cardiovascular disease. J Nutr. 2020;150(4):806–817. doi:10.1093/jn/nxz289
   PubMed Web of Science ®Google Scholar
• Koeth RA, Lam-Galvez BR, Kirsop J, et al. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. J Clin Invest. 2019;129(1):373–387. doi:10.1172/JCI94601
   PubMed Web of Science ®Google Scholar
• Liu B, Zhang L, Yang H, et al. Microbiota: a potential orchestrator of antidiabetic therapy. Front Endocrinol. 2023;14:973624. doi:10.3389/fendo.2023.973624
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi:10.1038/nature08821
   PubMed Web of Science ®Google Scholar
• Qin Y, Zhao J, Wang Y, et al. Specific alterations of gut microbiota in Chinese patients with hypertension: a systematic review and meta-analysis. Kidney Blood Press Res. 2022;47(7):433–447. doi:10.1159/000524282
   PubMed Web of Science ®Google Scholar
• Mushtaq N, Hussain S, Zhang S, et al. Molecular characterization of alterations in the intestinal microbiota of patients with grade 3 hypertension. Int J Mol Med. 2019;44(2):513–522. doi:10.3892/ijmm.2019.4235
   PubMed Web of Science ®Google Scholar
• Yan X, Jin J, Su X, et al. Intestinal flora modulates blood pressure by regulating the synthesis of intestinal-derived corticosterone in high salt-induced hypertension. Circ Res. 2020;126(7):839–853. doi:10.1161/CIRCRESAHA.119.316394
   PubMed Web of Science ®Google Scholar
• Dinakis E, Nakai M, Gill P, et al. Association between the gut microbiome and their metabolites with human blood pressure variability. Hypertension. 2022;79(8):1690–1701. doi:10.1161/HYPERTENSIONAHA.122.19350
   PubMed Web of Science ®Google Scholar
• Han ZL, Chen M, Fu XD, et al. Potassium alginate oligosaccharides alter gut microbiota, and have potential to prevent the development of hypertension and heart failure in spontaneously hypertensive rats. Int J Mol Sci. 2021;22(18):9823. doi:10.3390/ijms22189823
   PubMed Web of Science ®Google Scholar
• Fang C, Zuo K, Fu Y, et al. Aggravated gut microbiota and metabolomic imbalances are associated with hypertension patients comorbid with atrial fibrillation. Biomolecules. 2022;12(10):1445. doi:10.3390/biom12101445
   PubMed Web of Science ®Google Scholar
• Li H, Liu B, Song J, et al. Characteristics of gut microbiota in patients with hypertension and/or hyperlipidemia: a cross-sectional study on rural residents in Xinxiang County, Henan Province. Microorganisms. 2019;7(10):399. doi:10.3390/microorganisms7100399
   PubMed Web of Science ®Google Scholar
• Galla S, Chakraborty S, Cheng X, et al. Exposure to amoxicillin in early life is associated with changes in gut microbiota and reduction in blood pressure: findings from a study on rat dams and offspring. J Am Heart Assoc. 2020;9(2):e014373. doi:10.1161/JAHA.119.014373
   PubMed Web of Science ®Google Scholar
• Dan X, Mushi Z, Baili W, et al. Differential analysis of hypertension-associated intestinal microbiota. Int J Med Sci. 2019;16(6):872–881. doi:10.7150/ijms.29322
   PubMed Web of Science ®Google Scholar
• Yan Q, Gu Y, Li X, et al. Alterations of the Gut Microbiome in Hypertension. Front Cell Infect Microbiol. 2017;7:381. doi:10.3389/fcimb.2017.00381
   PubMed Web of Science ®Google Scholar
• Su C, Liu Y, Zhang H, et al. Investigation of the effects of antibiotic application on the intestinal flora in elderly hypertension patients with infectious diseases. Iran J Public Health. 2018;47(3):335–341.
   PubMed Web of Science ®Google Scholar
• Lakshmanan AP, Shatat IF, Zaidan S, et al. Bifidobacterium reduction is associated with high blood pressure in children with type 1 diabetes mellitus. Biomed Pharmacother. 2021;140:111736. doi:10.1016/j.biopha.2021.111736
   PubMed Web of Science ®Google Scholar
• Barton W, Penney NC, Cronin O, et al. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut. 2018;67(4):625–633. doi:10.1136/gutjnl-2016-313627
   PubMed Web of Science ®Google Scholar
• Kulecka M, Fraczek B, Mikula M, et al. The composition and richness of the gut microbiota differentiate the top Polish endurance athletes from sedentary controls. Gut Microbes. 2020;11(5):1374–1384. doi:10.1080/19490976.2020.1758009
   PubMed Web of Science ®Google Scholar
• Zhong F, Xu Y, Lai HY, et al. Effects of combined aerobic and resistance training on gut microbiota and cardiovascular risk factors in physically active elderly women: a randomized controlled trial. Front Physiol. 2022;13:1004863. doi:10.3389/fphys.2022.1004863
   PubMed Web of Science ®Google Scholar
• Wu S, Zheng C, Liu N, et al. Liuzijue training improves hypertension and modulates gut microbiota profile. Front Cardiovasc Med. 2023;10:1075084. doi:10.3389/fcvm.2023.1075084
   PubMed Web of Science ®Google Scholar
• Abboud FM, Cicha MZ, Ericsson A, et al. Altering early life gut microbiota has long-term effect on immune system and hypertension in spontaneously hypertensive rats. Front Physiol. 2021;12:752924. doi:10.3389/fphys.2021.752924
   PubMed Web of Science ®Google Scholar
• Magne F, Gotteland M, Gauthier L, et al. The Firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients. 2020;12(5):1474. doi:10.3390/nu12051474
   PubMed Web of Science ®Google Scholar
• Zhang GX, Jin L, Jin H, et al. Influence of dietary components and traditional Chinese medicine on hypertension: a potential role for gut microbiota. Evid Based Complement Alternat Med. 2021;2021:5563073. doi:10.1155/2021/5563073
   PubMed Web of Science ®Google Scholar
• Daliri EB, Ofosu FK, Chelliah R, et al. Influence of fermented soy protein consumption on hypertension and gut microbial modulation in spontaneous hypertensive rats. Biosci Microbiota Food Health. 2020;39(4):199–208. doi:10.12938/bmfh.2020-001
   PubMed Web of Science ®Google Scholar
• Wang Q, He Y, Li X, et al. Lactobacillus reuteri CCFM8631 alleviates hypercholesterolaemia caused by the paigen atherogenic diet by regulating the gut microbiota. Nutrients. 2022;14(6):1272. doi:10.3390/nu14061272
   PubMed Web of Science ®Google Scholar
• Cheng L, Chen Y, Zhang X, et al. A metagenomic analysis of the modulatory effect of Cyclocarya paliurus flavonoids on the intestinal microbiome in a high-fat diet-induced obesity mouse model. J Sci Food Agric. 2019;99(8):3967–3975. doi:10.1002/jsfa.9622
   PubMed Web of Science ®Google Scholar
• Qiu J, Zhou H, Jing Y, et al. Association between blood microbiome and type 2 diabetes mellitus: a nested case-control study. J Clin Lab Anal. 2019;33(4):e22842. doi:10.1002/jcla.22842
   PubMed Web of Science ®Google Scholar
• Veloo ACM, Baas WH, Haan FJ, et al. Prevalence of antimicrobial resistance genes in Bacteroides spp. and Prevotella spp. Dutch clinical isolates. Clin Microbiol Infect. 2019;25(9):1156.e9–1156.e13. doi:10.1016/j.cmi.2019.02.017
   PubMed Web of Science ®Google Scholar
• Ryan D, Prezza G, Westermann AJ. An RNA-centric view on gut Bacteroidetes. Biol Chem. 2020;402(1):55–72. doi:10.1515/hsz-2020-0230
   PubMed Web of Science ®Google Scholar
• Su M, Hao Z, Shi H, et al. Metagenomic analysis revealed differences in composition and function between liquid-associated and solid-associated microorganisms of sheep rumen. Front Microbiol. 2022;13:851567. doi:10.3389/fmicb.2022.851567
   PubMed Web of Science ®Google Scholar
• Pignatelli P, Romei FM, Bondi D, et al. Microbiota and oral cancer as a complex and dynamic microenvironment: a narrative review from etiology to prognosis. Int J Mol Sci. 2022;23(15):8323. doi:10.3390/ijms23158323
   PubMed Web of Science ®Google Scholar
• Gao J, Peng Y, Jiang N, et al. High-throughput sequencing-based analysis of changes in the vaginal microbiome during the disease course of patients with bacterial vaginosis: a case-control study. Biology. 2022;11(12):1797. doi:10.3390/biology11121797
   PubMedGoogle Scholar
• Ding L, Liu J, Zhou L, et al. A high-fat diet disrupts the hepatic and adipose circadian rhythms and modulates the diurnal rhythm of gut microbiota-derived short-chain fatty acids in gestational mice. Front Nutr. 2022;9:925390. doi:10.3389/fnut.2022.925390
   PubMed Web of Science ®Google Scholar
• Li Z, Zhou E, Liu C, et al. Dietary butyrate ameliorates metabolic health associated with selective proliferation of gut Lachnospiraceae bacterium 28-4. JCI Insight. 2023;8(4):e166655. doi:10.1172/jci.insight.166655
   PubMed Web of Science ®Google Scholar
• Sheikh Omar NM, Erismis B, Muse Osman M, et al. Retrospective evaluation of nosocomial bacterial infections and their antimicrobial resistance patterns among hospitalized patients in Mogadishu, Somalia. Infect Drug Resist. 2023;16:705–720. doi:10.2147/IDR.S398387
   PubMed Web of Science ®Google Scholar
• Rojas R, Macesic N, Tolari G, et al. Multidrug-Resistant Klebsiella pneumoniae ST307 in traveler returning from Puerto Rico to Dominican Republic. Emerg Infect Dis. 2019;25(8):1583–1585. doi:10.3201/eid2508.171730
   PubMed Web of Science ®Google Scholar
• Yue Y, Wang Y, Xie Q, et al. Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-κB and MAPK Signaling Pathways In Vivo. J Agric Food Chem. 2023;71(23):8915–8930. doi:10.1021/acs.jafc.3c00421
   PubMed Web of Science ®Google Scholar
• Chidambaram V, Gupte A, Wang JY, et al. The impact of hypertension and use of calcium channel blockers on tuberculosis treatment outcomes. Clin Infect Dis. 2021;73(9):e3409–e3418. doi:10.1093/cid/ciaa1446
   PubMed Web of Science ®Google Scholar
• Guo S, Lei S, Palittapongarnpim P, et al. Association between Mycobacterium tuberculosis genotype and diabetes mellitus/hypertension: a molecular study. BMC Infect Dis. 2022;22(1):401. doi:10.1186/s12879-022-07344-z
   PubMed Web of Science ®Google Scholar
• Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189–200. doi:10.1080/19490976.2015.1134082
   PubMed Web of Science ®Google Scholar
• Li L, Zhong SJ, Hu SY, et al. Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats. BMC Microbiol. 2021;21(1):141. doi:10.1186/s12866-021-02202-5
   PubMed Web of Science ®Google Scholar
• Zuo K, Fang C, Liu Z, et al. Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling. Int J Biol Sci. 2022;18(10):4219–4232. doi:10.7150/ijbs.70644
   PubMed Web of Science ®Google Scholar
• Thananimit S, Pahumunto N, Teanpaisan R. Characterization of short chain fatty acids produced by selected potential probiotic lactobacillus strains. Biomolecules. 2022;12(12):1829. doi:10.3390/biom12121829
   PubMed Web of Science ®Google Scholar
• Sun S, Lulla A, Sioda M, et al. Gut microbiota composition and blood pressure. Hypertension. 2019;73(5):998–1006. doi:10.1161/HYPERTENSIONAHA.118.12109
   PubMed Web of Science ®Google Scholar
• Soto-Martin EC, Warnke I, Farquharson FM, et al. Vitamin biosynthesis by human gut butyrate-producing bacteria and cross-feeding in synthetic microbial communities. mBio. 2020;11(4):e00886–20. doi:10.1128/mBio.00886-20
   PubMed Web of Science ®Google Scholar
• Tilves C, Yeh HC, Maruthur N, et al. Increases in circulating and fecal butyrate are associated with reduced blood pressure and hypertension: results from the SPIRIT trial. J Am Heart Assoc. 2022;11(13):e024763. doi:10.1161/JAHA.121.024763
   PubMed Web of Science ®Google Scholar
• Li G, Tian Y, Zhu WG. The roles of histone deacetylases and their inhibitors in cancer therapy. Front Cell Dev Biol. 2020;8:576946. doi:10.3389/fcell.2020.576946
   PubMed Web of Science ®Google Scholar
• Makkar R, Behl T, Arora S. Role of HDAC inhibitors in diabetes mellitus. Curr Res Transl Med. 2020;68(2):45–50. doi:10.1016/j.retram.2019.08.001
   PubMed Web of Science ®Google Scholar
• Hsu CN, Yu HR, Lin IC, et al. Sodium butyrate modulates blood pressure and gut microbiota in maternal tryptophan-free diet-induced hypertension rat offspring. J Nutr Biochem. 2022;108:109090. doi:10.1016/j.jnutbio.2022.109090
   PubMed Web of Science ®Google Scholar
• Robles-Vera I, Toral M, de la Visitación N, et al. Probiotics prevent dysbiosis and the rise in blood pressure in genetic hypertension: role of short-chain fatty acids. Mol Nutr Food Res. 2020;64(6):e1900616. doi:10.1002/mnfr.201900616
   PubMed Web of Science ®Google Scholar
• Le Roy T, Moens de Hase E, Van Hul M, et al. Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice. Gut. 2022;71(3):534–543. doi:10.1136/gutjnl-2020-323778
   PubMed Web of Science ®Google Scholar
• Le Sayec M, Xu Y, Laiola M, et al. The effects of Aronia berry (poly)phenol supplementation on arterial function and the gut microbiome in middle aged men and women: results from a randomized controlled trial. Clin Nutr. 2022;41(11):2549–2561. doi:10.1016/j.clnu.2022.08.024
   PubMed Web of Science ®Google Scholar
• Ilyés T, Silaghi CN, Crăciun AM. Diet-related changes of short-chain fatty acids in blood and feces in obesity and metabolic syndrome. Biology. 2022;11(11):1556. doi:10.3390/biology11111556
   PubMedGoogle Scholar
• Xu J, Moore BN, Pluznick JL. Short-chain fatty acid receptors and blood pressure regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021. Hypertension. 2022;79(10):2127–2137. doi:10.1161/HYPERTENSIONAHA.122.18558
   PubMed Web of Science ®Google Scholar
• Dardi P, Dos Santos-Eichler RA, de Oliveira S, et al. Reduced intestinal butyrate availability is associated with the vascular remodeling in resistance arteries of hypertensive rats. Front Physiol. 2022;13:998362. doi:10.3389/fphys.2022.998362
   PubMed Web of Science ®Google Scholar
• Kaye DM, Shihata WA, Jama HA, et al. Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease. Circulation. 2020;141(17):1393–1403. doi:10.1161/CIRCULATIONAHA.119.043081
   PubMed Web of Science ®Google Scholar
• Hsu CN, Hou CY, Chang CI, et al. Resveratrol butyrate ester protects adenine-treated rats against hypertension and kidney disease by Regulating the Gut-Kidney Axis. Antioxidants. 2021;11(1):83. doi:10.3390/antiox11010083
   Web of Science ®Google Scholar
• Zeisel SH, Warrier M. Trimethylamine N-Oxide, the microbiome, and heart and kidney disease. Annu Rev Nutr. 2017;37:157–181. doi:10.1146/annurev-nutr-071816-064732
   PubMed Web of Science ®Google Scholar
• Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576–585. doi:10.1038/nm.3145
   PubMed Web of Science ®Google Scholar
• Maksymiuk KM, Szudzik M, Gawryś-Kopczyńska M, et al. Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats. J Transl Med. 2022;20(1):470. doi:10.1186/s12967-022-03687-y
   PubMed Web of Science ®Google Scholar
• Romano KA, Vivas EI, Amador-Noguez D, et al. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio. 2015;6(2):e02481. doi:10.1128/mBio.02481-14
   PubMed Web of Science ®Google Scholar
• Brunt VE, Greenberg NT, Sapinsley ZJ, et al. Suppression of trimethylamine N-oxide with DMB mitigates vascular dysfunction, exercise intolerance, and frailty associated with a Western-style diet in mice. J Appl Physiol. 2022;133(4):798–813. doi:10.1152/japplphysiol.00350.2022
   PubMed Web of Science ®Google Scholar
• Oh S, Shim M, Son M, et al. Attenuating effects of dieckol on endothelial cell dysfunction via modulation of Th17/Treg balance in the intestine and aorta of spontaneously hypertensive rats. Antioxidants. 2021;10(2):298. doi:10.3390/antiox10020298
   Web of Science ®Google Scholar
• Madhur MS, Elijovich F, Alexander MR, et al. Hypertension: do inflammation and immunity hold the key to solving this epidemic? Circ Res. 2021;128(7):908–933. doi:10.1161/CIRCRESAHA.121.318052
   PubMed Web of Science ®Google Scholar
• Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63. doi:10.1038/nature09922
   PubMed Web of Science ®Google Scholar
• Barrea L, Muscogiuri G, Annunziata G, et al. A new light on vitamin d in obesity: a novel association with Trimethylamine-N-Oxide (TMAO). Nutrients. 2019;11(6):1310. doi:10.3390/nu11061310
   PubMed Web of Science ®Google Scholar
• Al-Rubaye H, Perfetti G, Kaski JC. The role of microbiota in cardiovascular risk: focus on trimethylamine oxide. Curr Probl Cardiol. 2019;44(6):182–196. doi:10.1016/j.cpcardiol.2018.06.005
   PubMed Web of Science ®Google Scholar
• Krishnan S, O’Connor LE, Wang Y, et al. Adopting a Mediterranean-style eating pattern with low, but not moderate, unprocessed, lean red meat intake reduces fasting serum trimethylamine N-oxide (TMAO) in adults who are overweight or obese. Br J Nutr. 2022;128(9):1–21. doi:10.1017/S0007114521004694
   Web of Science ®Google Scholar
• Ge X, Zheng L, Zhuang R, et al. The gut microbial metabolite trimethylamine N-Oxide and hypertension risk: a systematic review and dose-response meta-analysis. Adv Nutr. 2020;11(1):66–76. doi:10.1093/advances/nmz064
   PubMed Web of Science ®Google Scholar
• Wang Z, Roberts AB, Buffa JA, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163(7):1585–1595. doi:10.1016/j.cell.2015.11.055
   PubMed Web of Science ®Google Scholar
• Allaway D, Haydock R, Lonsdale ZN, et al. Rapid reconstitution of the fecal microbiome after extended diet-induced changes indicates a stable gut microbiome in healthy adult dogs. Appl Environ Microbiol. 2020;86(13):e00562–20. doi:10.1128/AEM.00562-20
   PubMed Web of Science ®Google Scholar
• Zhang HX, Li YY, Liu ZJ, et al. Quercetin effectively improves LPS-induced intestinal inflammation, pyroptosis, and disruption of the barrier function through the TLR4/NF-κB/NLRP3 signaling pathway in vivo and in vitro. Food Nutr Res. 2022;66:8948. doi:10.29219/fnr.v66.8948
   Web of Science ®Google Scholar
• Liu J, Chang G, Huang J, et al. Sodium butyrate inhibits the inflammation of lipopolysaccharide-induced acute lung injury in mice by regulating the Toll-Like Receptor 4/Nuclear Factor κB signaling pathway. J Agric Food Chem. 2019;67(6):1674–1682. doi:10.1021/acs.jafc.8b06359
   PubMed Web of Science ®Google Scholar
• Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2021;78(4):1233–1261. doi:10.1007/s00018-020-03656-y
   PubMed Web of Science ®Google Scholar
• Wang H, Song W, Wu Q, et al. Fecal transplantation from db/db mice treated with sodium butyrate attenuates ischemic stroke injury. Microbiol Spectr. 2021;9(2):e00042–21. doi:10.1128/Spectrum.00042-21
   PubMed Web of Science ®Google Scholar
• Cao N, Lan C, Chen C, et al. Prenatal lipopolysaccharides exposure induces transgenerational inheritance of hypertension. Circulation. 2022;146(14):1082–1095. doi:10.1161/CIRCULATIONAHA.122.059891
   PubMed Web of Science ®Google Scholar
• Li G, Wei W, Suo L, et al. Low-dose aspirin prevents kidney damage in LPS-induced preeclampsia by inhibiting the WNT5A and NF-κB signaling pathways. Front Endocrinol. 2021;12:639592. doi:10.3389/fendo.2021.639592
   PubMed Web of Science ®Google Scholar
• Santisteban MM, Qi Y, Zubcevic J, et al. Hypertension-linked pathophysiological alterations in the gut. Circ Res. 2017;120(2):312–323. doi:10.1161/CIRCRESAHA.116.309006
   PubMed Web of Science ®Google Scholar
• Ye C, Zheng F, Wang JX, et al. Dysregulation of the excitatory renal reflex in the sympathetic activation of spontaneously hypertensive rat. Front Physiol. 2021;12:673950. doi:10.3389/fphys.2021.673950
   PubMed Web of Science ®Google Scholar
• Haburčák M, Harrison J, Buyukozturk MM, et al. Heightened sympathetic neuron activity and altered cardiomyocyte properties in spontaneously hypertensive rats during the postnatal period. Front Synaptic Neurosci. 2022;14:995474. doi:10.3389/fnsyn.2022.995474
   PubMed Web of Science ®Google Scholar
• Qi J, Fu LY, Liu KL, et al. Resveratrol in the hypothalamic paraventricular nucleus attenuates hypertension by regulation of ROS and neurotransmitters. Nutrients. 2022;14(19):4177. doi:10.3390/nu14194177
   PubMed Web of Science ®Google Scholar
• Gao HL, Yu XJ, Feng YQ, et al. Luteolin attenuates hypertension via inhibiting NF-κB-mediated inflammation and PI3K/Akt signaling pathway in the hypothalamic paraventricular nucleus. Nutrients. 2023;15(3):502. doi:10.3390/nu15030502
   PubMed Web of Science ®Google Scholar
• Xia WJ, Xu ML, Yu XJ, et al. Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat. Gut Microbes. 2021;13(1):1–24. doi:10.1080/19490976.2020.1854642
   PubMed Web of Science ®Google Scholar
• Pan Y, Sun S, Wang X, et al. Improvement of vascular function by knockdown of salusin-β in hypertensive rats via nitric oxide and reactive oxygen species signaling pathway. Front Physiol. 2021;12:622954. doi:10.3389/fphys.2021.622954
   PubMed Web of Science ®Google Scholar
• Sun S, Zhang F, Pan Y, et al. A TOR2A gene product: salusin-β contributes to attenuated vasodilatation of spontaneously hypertensive rats. Cardiovasc Drugs Ther. 2021;35(1):125–139. doi:10.1007/s10557-020-06983-1
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–563. doi:10.1038/nature12820
   PubMed Web of Science ®Google Scholar
• Wan Y, Yuan J, Li J, et al. Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: a 6-month randomized controlled-feeding trial. Clin Nutr. 2020;39(2):395–404. doi:10.1016/j.clnu.2019.02.037
   PubMed Web of Science ®Google Scholar
• Cho KY. Lifestyle modifications result in alterations in the gut microbiota in obese children. BMC Microbiol. 2021;21(1):10. doi:10.1186/s12866-020-02002-3
   PubMed Web of Science ®Google Scholar
• Andújar-Tenorio N, Prieto I, Cobo A, et al. High fat diets induce early changes in gut microbiota that may serve as markers of ulterior altered physiological and biochemical parameters related to metabolic syndrome. Effect of virgin olive oil in comparison to butter. PLoS One. 2022;17(8):e0271634. doi:10.1371/journal.pone.0271634
   PubMed Web of Science ®Google Scholar
• Vileigas DF, Marciano CLC, Mota GAF, et al. Temporal measures in cardiac structure and function during the development of obesity induced by different types of western diet in a rat model. Nutrients. 2019;12(1):68. doi:10.3390/nu12010068
   PubMed Web of Science ®Google Scholar
• Filippou CD, Tsioufis CP, Thomopoulos CG, et al. Dietary Approaches to Stop Hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2020;11(5):1150–1160. doi:10.1093/advances/nmaa041
   PubMed Web of Science ®Google Scholar
• Li J, Guasch-Ferré M, Chung W, et al. The Mediterranean diet, plasma metabolome, and cardiovascular disease risk. Eur Heart J. 2020;41(28):2645–2656. doi:10.1093/eurheartj/ehaa209
   PubMed Web of Science ®Google Scholar
• Schwingshackl L, Chaimani A, Schwedhelm C, et al. Comparative effects of different dietary approaches on blood pressure in hypertensive and pre-hypertensive patients: a systematic review and network meta-analysis. Crit Rev Food Sci Nutr. 2019;59(16):2674–2687. doi:10.1080/10408398.2018.1463967
   PubMed Web of Science ®Google Scholar
• Jennings A, Berendsen AM, de Groot GM, et al. Mediterranean-style diet improves systolic blood pressure and arterial stiffness in older adults. Hypertension. 2019;73(3):578–586. doi:10.1161/HYPERTENSIONAHA.118.12259
   PubMed Web of Science ®Google Scholar
• Nagpal R, Shively CA, Appt SA, et al. Gut microbiome composition in non-human primates consuming a western or Mediterranean diet. Front Nutr. 2018;5:28. doi:10.3389/fnut.2018.00028
   PubMed Web of Science ®Google Scholar
• Belanger MJ, Kovell LC, Turkson-Ocran RA, et al. Effects of the dietary approaches to stop hypertension diet on change in cardiac biomarkers over time: results from the DASH-sodium trial. J Am Heart Assoc. 2023;12(2):e026684. doi:10.1161/JAHA.122.026684
   PubMed Web of Science ®Google Scholar
• Cramer H, Sellin C, Schumann D, et al. Yoga in arterial hypertension. Dtsch Arztebl Int. 2018;115(50):833–839. doi:10.3238/arztebl.2018.0833
   PubMed Web of Science ®Google Scholar
• Nalbant G, Hassanein ZM, Lewis S, et al. Content, structure, and delivery characteristics of yoga interventions for managing hypertension: a systematic review and meta-analysis of randomized controlled trials. Front Public Health. 2022;10:846231. doi:10.3389/fpubh.2022.846231
   PubMed Web of Science ®Google Scholar
• Rocha J, Cunha FA, Cordeiro R, et al. Acute effect of a single session of pilates on blood pressure and cardiac autonomic control in middle-aged adults with hypertension. J Strength Cond Res. 2020;34(1):114–123. doi:10.1519/JSC.0000000000003060
   PubMed Web of Science ®Google Scholar
• Dai L, Jiang Y, Wang P, et al. Effects of three traditional Chinese fitness exercises combined with antihypertensive drugs on patients with essential hypertension: a systematic review and network meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2021;2021:2570472. doi:10.1155/2021/2570472
   PubMed Web of Science ®Google Scholar
• Iyonaga T, Shinohara K, Mastuura T, et al. Brain perivascular macrophages contribute to the development of hypertension in stroke-prone spontaneously hypertensive rats via sympathetic activation. Hypertens Res. 2020;43(2):99–110. doi:10.1038/s41440-019-0333-4
   PubMed Web of Science ®Google Scholar
• Syme C, Shin J, Richer L, et al. Sex differences in blood pressure hemodynamics in middle-aged adults with overweight and obesity. Hypertension. 2019;74(2):407–412. doi:10.1161/HYPERTENSIONAHA.119.13058
   PubMed Web of Science ®Google Scholar
• Matsukawa K, Iwamoto GA, Mitchell JH, et al. Exaggerated renal sympathetic nerve and pressor responses during spontaneously occurring motor activity in hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2023;324(4):R497–R512. doi:10.1152/ajpregu.00271.2022
   PubMed Web of Science ®Google Scholar
• DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol. 2014;10(6):364–376. doi:10.1038/nrendo.2014.44
   PubMed Web of Science ®Google Scholar
• An J, Zhao X, Wang Y, et al. Western-style diet impedes colonization and clearance of Citrobacter rodentium. PLoS Pathog. 2021;17(4):e1009497. doi:10.1371/journal.ppat.1009497
   PubMed Web of Science ®Google Scholar
• Bier A, Braun T, Khasbab R, et al. A high salt diet modulates the gut microbiota and short chain fatty acids production in a salt-sensitive hypertension rat model. Nutrients. 2018;10(9):1154. doi:10.3390/nu10091154
   PubMed Web of Science ®Google Scholar
• Miranda PM, De Palma G, Serkis V, et al. High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production. Microbiome. 2018;6(1):57. doi:10.1186/s40168-018-0433-4
   PubMedGoogle Scholar
• Rebholz CM, Lichtenstein AH, Zheng Z, et al. Serum untargeted metabolomic profile of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern. Am J Clin Nutr. 2018;108(2):243–255. doi:10.1093/ajcn/nqy099
   PubMed Web of Science ®Google Scholar
• Liu Q, Yu Z, Tian F, et al. Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier. Microb Cell Fact. 2020;19(1):23. doi:10.1186/s12934-020-1289-4
   PubMed Web of Science ®Google Scholar
• Zhou L, Ding C, Wu J, et al. Probiotics and synbiotics show clinical efficacy in treating gestational diabetes mellitus: a meta-analysis. Prim Care Diabetes. 2021;15(6):937–947. doi:10.1016/j.pcd.2021.08.005
   PubMed Web of Science ®Google Scholar
• de Almeida Silva M, Mowry FE, Peaden SC, et al. Kefir ameliorates hypertension via gut-brain mechanisms in spontaneously hypertensive rats. J Nutr Biochem. 2020;77:108318. doi:10.1016/j.jnutbio.2019.108318
   PubMed Web of Science ®Google Scholar
• Chi C, Li C, Wu D, et al. Effects of probiotics on patients with hypertension: a systematic review and meta-analysis. Curr Hypertens Rep. 2020;22(5):34. doi:10.1007/s11906-020-01042-4
   PubMedGoogle Scholar
• Hsu CN, Hou CY, Chan JYH, et al. Hypertension programmed by perinatal high-fat diet: effect of maternal gut microbiota-targeted therapy. Nutrients. 2019;11(12):2908. doi:10.3390/nu11122908
   PubMed Web of Science ®Google Scholar
• Fan L, Ren J, Chen Y, et al. Effect of fecal microbiota transplantation on primary hypertension and the underlying mechanism of gut microbiome restoration: protocol of a randomized, blinded, placebo-controlled study. Trials. 2022;23(1):178. doi:10.1186/s13063-022-06086-2
   PubMed Web of Science ®Google Scholar
• Robles-Vera I, Toral M, de la Visitación N, et al. Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects. Br J Pharmacol. 2020;177(9):2006–2023. doi:10.1111/bph.14965
   PubMed Web of Science ®Google Scholar
• Kim TT, Parajuli N, Sung MM, et al. Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice. Am J Physiol Endocrinol Metab. 2018;315(4):E511–E519. doi:10.1152/ajpendo.00471.2017
   PubMed Web of Science ®Google Scholar
• Lai CY, Sung J, Cheng F, et al. Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation. Aliment Pharmacol Ther. 2019;49(4):354–363. doi:10.1111/apt.15116
   PubMed Web of Science ®Google Scholar
• Dawwas GK, Brensinger CM, Vajravelu RK, et al. Long-term outcomes following multiply recurrent clostridioides difficile infection and fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2022;20(4):806–816.e6. doi:10.1016/j.cgh.2020.12.004
   PubMed Web of Science ®Google Scholar
• Lopetuso LR, Ianiro G, Allegretti JR, et al. Fecal transplantation for ulcerative colitis: current evidence and future applications. Expert Opin Biol Ther. 2020;20(4):343–351. doi:10.1080/14712598.2020.1733964
   PubMed Web of Science ®Google Scholar
• Cheng Y, Ling Z, Li L. The intestinal microbiota and colorectal cancer. Front Immunol. 2020;11:615056. doi:10.3389/fimmu.2020.615056
   PubMed Web of Science ®Google Scholar
• Alvarez-Silva C, Kashani A, Hansen TH, et al. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India. Genome Med. 2021;13(1):37. doi:10.1186/s13073-021-00856-4
   PubMed Web of Science ®Google Scholar
• Xu YQ, Yuan JL, Niu HT. Progress in research on the prevention of hypertension by regulating intestinal flora with traditional Chinese medicine. Chin J Microecol. 2021;5:599–602+608. doi:10.13381/j.cnki.cjm.202105022
   Google Scholar
• Yang M, Lao L. Emerging applications of metabolomics in traditional Chinese medicine treating hypertension: biomarkers, pathways and more. Front Pharmacol. 2019;10:158. doi:10.3389/fphar.2019.00158
   PubMed Web of Science ®Google Scholar
• Ma XC, Xiong XJ, Mo Y, et al. Study on changes of intestinal microflora in spontaneous sly hypertensive rats based on 16S rDNA sequencing and intervention of traditional Chinese Medicine. Chinese Archives Traditional Chin Med. 2020;8:71–74+265–266. doi:10.13193/j.issn.1673-7717.2020.08.017
   Google Scholar
• Luo K, Zhao H, Bian B, et al. Huanglian Jiedu Decoction in the treatment of the Traditional Chinese Medicine Syndrome “Shanghuo”-an intervention study. Front Pharmacol. 2021;12:616318. doi:10.3389/fphar.2021.616318
   PubMed Web of Science ®Google Scholar
• Li X, Wei S, Ma X, et al. Huanglian Jiedu Decoction Exerts Antipyretic effect by inhibiting MAPK signaling pathway. Evid Based Complement Alternat Med. 2021;2021:2209574. doi:10.1155/2021/2209574
   PubMed Web of Science ®Google Scholar
• Yue GH, Zhuo SY, Xia M, et al. Effect of huanglian jiedu decoction on thoracic aorta gene expression in spontaneous hypertensive rats. Evid Based Complement Alternat Med. 2014;2014:565784. doi:10.1155/2014/565784
   PubMed Web of Science ®Google Scholar
• Xie PC, Liang QE, Tu WQ, et al. The effect of Taohong Siwu decoction combined with antihypertensive medicine in the treatment of hypertension: meta-analysis. Medicine. 2022;101(49):e32133. doi:10.1097/MD.0000000000032133
   PubMed Web of Science ®Google Scholar
• Weng JQ, Li JB, Yuan MF, et al. Effects of Buyang Huanwu decoction on intestinal barrier, intestinal flora, and trimethylamine oxide in rats with heart failure. Chin J Integr Med. 2023;29(2):155–161. doi:10.1007/s11655-022-2898-z
   PubMed Web of Science ®Google Scholar
• Li H, Xie HB, Qi R, et al. Effect of regulation of intestinal flora with the Cheqianzi Cuduotang capsules on blood pressure in elderly patients with hypertension. Clin J Chin Med. 2019;11(11):15–19.
   Google Scholar
• Qi YZ, Jiang YH, Jiang LY, et al. Effects of Eucommia ulmoides-Tribulus terrestris on intestinal microbiota in aged spontaneously hypertensive rats. Chin J Hypertens. 2019;5:454–462. doi:10.16439/j.cnki.1673-7245.2019.05.017
   Google Scholar
• Xu X, Tian W, Duan W, et al. Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Front Pharmacol. 2023;13:1014410. doi:10.3389/fphar.2022.1014410
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang X, Jin H, et al. Zhengganxifeng decoction affects gut microbiota and reduces blood pressure via renin-angiotensin system. Biol Pharm Bull. 2019;42(9):1482–1490. doi:10.1248/bpb.b19-00057
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang P, Li H, et al. Zhijing powder manages blood pressure by regulating PI3K/AKT signal pathway in hypertensive rats. Heliyon. 2023;9(1):e12777. doi:10.1016/j.heliyon.2022.e12777
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang D, Bai X, et al. The impact of Traditional Chinese Medicine on mouse gut microbiota abundances and interactions based on Granger causality and pathway analysis. Front Microbiol. 2022;13:980082. doi:10.3389/fmicb.2022.980082
   PubMed Web of Science ®Google Scholar